Example of Vascular Medicine format
Recent searches

Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format Example of Vascular Medicine format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Vascular Medicine — Template for authors

Publisher: SAGE
Categories Rank Trend in last 3 yrs
Cardiology and Cardiovascular Medicine #103 of 317 up up by 22 ranks
journal-quality-icon Journal quality:
Good
calendar-icon Last 4 years overview: 276 Published Papers | 1018 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 28/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

SAGE

Quality:  
High
CiteRatio: 4.8
SJR: 1.164
SNIP: 1.22
open access Open Access
recommended Recommended

SAGE

Quality:  
High
CiteRatio: 5.5
SJR: 1.72
SNIP: 1.405
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 7.8
SJR: 1.711
SNIP: 1.346
open access Open Access

Springer

Quality:  
High
CiteRatio: 5.1
SJR: 1.063
SNIP: 0.959

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

2.509

16% from 2018

Impact factor for Vascular Medicine from 2016 - 2019
Year Value
2019 2.509
2018 2.158
2017 2.393
2016 1.866
graph view Graph view
table view Table view

3.7

3% from 2019

CiteRatio for Vascular Medicine from 2016 - 2020
Year Value
2020 3.7
2019 3.6
2018 3.8
2017 3.2
2016 2.5
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 16% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 3% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.838

4% from 2019

SJR for Vascular Medicine from 2016 - 2020
Year Value
2020 0.838
2019 0.87
2018 0.927
2017 0.793
2016 0.77
graph view Graph view
table view Table view

1.203

17% from 2019

SNIP for Vascular Medicine from 2016 - 2020
Year Value
2020 1.203
2019 1.031
2018 1.096
2017 1.076
2016 0.855
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 4% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 17% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Vascular Medicine

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

SAGE

Vascular Medicine

Vascular Medicine is dedicated to advancing the field of vascular medicine by publishing the latest clinical and scientific information in vascular medicine and related specialties. The content of Vascular Medicine includes original research articles, reviews, case reports, ed...... Read More

Medicine

i
Last updated on
27 Jun 2020
i
ISSN
1358-863X
i
Impact Factor
Medium - 0.964
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SageV
i
Citation Type
Numbered (Superscripted)
25
i
Bibliography Example
Blonder GE, Tinkham M and Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B 1982; 25(7): 4515–4532. URL 10.1103/PhysRevB.25.4515.

Top papers written in this journal

Journal Article DOI: 10.1177/1358863X9700200310
The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk
Michael H. Criqui1, Julie O. Denenberg1, Robert Langer1, Arnost Fronek1
01 Aug 1997 - Vascular Medicine

Abstract:

Data from the Framingham Study and other population studies indicate that intermittent claudication (IC) sharply increases in late middle age and is somewhat higher among men than women. Noninvasive testing in populations indicates that the true prevalence of peripheral arterial disease (PAD) is at least five times higher tha... Data from the Framingham Study and other population studies indicate that intermittent claudication (IC) sharply increases in late middle age and is somewhat higher among men than women. Noninvasive testing in populations indicates that the true prevalence of peripheral arterial disease (PAD) is at least five times higher than would be expected based on the reported prevalence of IC. Peripheral arterial disease correlates most strongly with cigarette smoking and either diabetes or impaired glucose tolerance. Other risk factors for PAD include hypertension; low levels of high-density lipoprotein cholesterol; and high levels of triglycerides, apolipoprotein B, lipoprotein(a), homocysteine, fibrinogen and blood viscosity. Individuals with PAD are more likely to have coronary heart disease and cerebrovascular disease than those without PAD. Because of the high risk of both nonfatal and fatal cardiovascular disease (CVD) events in PAD patients, individuals with evidence of PAD should undergo both a careful examination of the entire cardiovascular system and aggressive modification of CVD risk factors. read more read less

Topics:

Framingham Risk Score (63%)63% related to the paper, Intermittent claudication (57%)57% related to the paper, Framingham Heart Study (57%)57% related to the paper, Blood viscosity (54%)54% related to the paper, Impaired glucose tolerance (53%)53% related to the paper
View PDF
452 Citations
open accessOpen access Journal Article DOI: 10.1177/1358836X9800300209
Lymphedema: classification, diagnosis and therapy:
Andrzej Szuba1, Stanley G. Rockson1
01 May 1998 - Vascular Medicine

Abstract:

This review presents the diagnostic features, the pathophysiology and the available therapies for lymphedema. This disease is often able to be diagnosed by its characteristic clinic- cal presentation, yet, in some cases, ancillary tests might be necessary to establish the diag- nosis, particularly in the early stages of the d... This review presents the diagnostic features, the pathophysiology and the available therapies for lymphedema. This disease is often able to be diagnosed by its characteristic clinic- cal presentation, yet, in some cases, ancillary tests might be necessary to establish the diag- nosis, particularly in the early stages of the disease and in edemas of mixed etiology. These diagnostic modalities are also useful in clinical studies. Available modalities include isotopic lymphoscintigraphy, indirect and direct lymphography, magnetic resonance imaging, computed tomography and ultrasonography. Lymphedema may be primary or secondary to the presence of other diseases and/or to the consequences of sur- gery. Primary lymphedema may occur at any phase of life but it most commonly appears at puberty. Secondary lymphedema is encountered more often. The most prevalent worldwide cause of lymphedema is filariasis, which is particularly common in south-east Asia. In the USA, postsurgical lymphedema of the extremity prevails. Complications of chronic limb lymphedema include recurrent cellulitis and lymphangiosarcoma. Most patients are treated conservatively, by means of various forms of compression therapy, including complex physical therapy, pneumatic pumps and compressive garments. Volume reducing surgery is performed rarely. Lymphatic microsurgery is still in an experimental stage, although a few centers consistently report favorable outcomes. read more read less

Topics:

Primary lymphedema (80%)80% related to the paper, Secondary lymphedema (70%)70% related to the paper, Lymphedema (65%)65% related to the paper, Lymphangiosarcoma (59%)59% related to the paper
View PDF
381 Citations
open accessOpen access Journal Article DOI: 10.1177/1358836X0100600I102
Peripheral arterial disease - epidemiological aspects
Michael H. Criqui1
01 Feb 2001 - Vascular Medicine

Abstract:

As many as 10 million people in the USA have peripheral arterial disease (PAD) with a prevalence over 10% in people aged more than 60 years old. Generally, men have a higher prevalence of PAD than women. The risk factors for PAD are similar to those for coronary artery disease (CAD) and cerebrovascular disease (CBVD), but dia... As many as 10 million people in the USA have peripheral arterial disease (PAD) with a prevalence over 10% in people aged more than 60 years old. Generally, men have a higher prevalence of PAD than women. The risk factors for PAD are similar to those for coronary artery disease (CAD) and cerebrovascular disease (CBVD), but diabetes and cigarette smoking have a particularly strong association with PAD. Patients with PAD also have CAD and CBVD as co-morbidities, although the extent of co-morbidity depends on the sensitivity of assessment. The risk of mortality is proportional to the severity of PAD, and the relative risk of all-cause mortality due to PAD is unaltered by the presence of CAD or CBVD. PAD is under-recognized and under-treated, even though it should be regarded as a severe disease leading to significant death and disability from stroke and myocardial infarction (MI). Thus, accurate diagnosis of PAD could provide an early indication of the need for intervention and help prevent future morbidity and mortality. read more read less

Topics:

Risk factor (52%)52% related to the paper, Risk of mortality (51%)51% related to the paper, Coronary artery disease (50%)50% related to the paper
339 Citations
open accessOpen access Journal Article DOI: 10.1177/1358863X08089277
National health care costs of peripheral arterial disease in the Medicare population
Alan T. Hirsch1, Lacey K. Hartman, Robert J. Town1, Beth A Virnig
01 Aug 2008 - Vascular Medicine

Abstract:

Lower extremity peripheral arterial disease (PAD) is prevalent in the Medicare population and is associated with high rates of myocardial infarction, stroke, amputation, and death. Nevertheless, national health expenditures for PAD are not known. We hypothesized that PAD-related costs are high, increase with age, and that tre... Lower extremity peripheral arterial disease (PAD) is prevalent in the Medicare population and is associated with high rates of myocardial infarction, stroke, amputation, and death. Nevertheless, national health expenditures for PAD are not known. We hypothesized that PAD-related costs are high, increase with age, and that treatment rates would be less than known PAD prevalence. The objective was to determine national health care expenditures for PAD in the United States. PAD-related treatment costs were calculated in the elderly, non-disabled Medicare population. The cost analysis relied on the 5% control population for the linked SEER-Medicare data and Medicare claims for the calendar year 2001, identifying PAD cases based on diagnosis and procedure codes. Costs were aggregated separately for inpatient and outpatient treatment and estimates adjusted to reflect the Medicare population. A total of $4.37 billion was spent on PAD-related treatment and 88% of expenditures were for inpatient care. Medicare program outlays totaled $3.87 billion, while enrollees (or their supplemental insurance) spent the remaining $500 million. In total, 6.8% of the elderly Medicare population received treatment for PAD. Treatment increased with age at rates of 4.5%, 7.5%, and 11.8% for individuals aged 65-74, 75-84, and >85 years, respectively. PAD-related costs accounted for approximately 13% of all Medicare Part A and B expenditures for the PAD-treated cohort, and 2.3% of total Medicare Part A and B expenditures. In conclusion, US national PAD-related costs are high, associated with inpatient care, and increase with age. PAD is treated at rates lower than the known PAD prevalence as only approximately one-third of the population with known PAD had detectable PAD-related health care costs in our analysis. The potential impact of earlier PAD detection and use of outpatient preventive strategies on total national PAD health care costs is unknown. read more read less

Topics:

Population (56%)56% related to the paper
View PDF
321 Citations
open accessOpen access Journal Article DOI: 10.1177/1358863X9700200109
Thromboangiitis obliterans (Buerger's disease)
Mahmoud B Aqel1, Jeffrey W. Olin1
01 Jan 1997 - Vascular Medicine

Abstract:

Thromboangiitis obliterans (TAO) is a nonatherosclerotic segmental inflammatory obliterative disease that most commonly affects the small- and medium-sized arteries and veins in both upper and lower extremities. In the past, TAO was exclusively a disease confined to men; however, recently more women have been diagnosed with T... Thromboangiitis obliterans (TAO) is a nonatherosclerotic segmental inflammatory obliterative disease that most commonly affects the small- and medium-sized arteries and veins in both upper and lower extremities. In the past, TAO was exclusively a disease confined to men; however, recently more women have been diagnosed with TAO. Most patients are heavy users of tobacco, and usually cigarette smokers. read more read less

Topics:

Buerger's disease (65%)65% related to the paper, Giant cell arteritis (53%)53% related to the paper, Popliteal artery entrapment syndrome (52%)52% related to the paper
View PDF
319 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Vascular Medicine.

It automatically formats your research paper to SAGE formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Vascular Medicine format uses SageV citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Vascular Medicine in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Vascular Medicine guidelines and auto format it.

2. Do you follow the Vascular Medicine guidelines?

Yes, the template is compliant with the Vascular Medicine guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Vascular Medicine?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Vascular Medicine citation style.

4. Can I use the Vascular Medicine templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Vascular Medicine.

5. Can I use a manuscript in Vascular Medicine that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Vascular Medicine that you can download at the end.

6. How long does it usually take you to format my papers in Vascular Medicine?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Vascular Medicine.

7. Where can I find the template for the Vascular Medicine?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Vascular Medicine's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Vascular Medicine's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Vascular Medicine an online tool or is there a desktop version?

SciSpace's Vascular Medicine is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Vascular Medicine?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Vascular Medicine?”

11. What is the output that I would get after using Vascular Medicine?

After writing your paper autoformatting in Vascular Medicine, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Vascular Medicine's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Vascular Medicine?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Vascular Medicine. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Vascular Medicine?

The 5 most common citation types in order of usage for Vascular Medicine are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Vascular Medicine?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Vascular Medicine's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Vascular Medicine in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Vascular Medicine Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Vascular Medicine formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template